Clinical trial Recruiting at 1 site Interventional Ages 65 to 100

Lumbar nerve block comparison in older adults having spine surgery

Official title: A Prospective, Randomized Controlled Trial Comparing the Analgesic Efficacy of Lumbar Paravertebral Block and Lumbar Erector Spinae Plane Block in Elderly Patients Undergoing Lumbar Spine Surgery

Run by Poznan University of Medical Sciences · NCT07607509 · Data updated 2026-11-12

This study tests whether a lumbar paravertebral block or a lumbar erector spinae plane block provides better pain control and reduces opioid use in people 65 and older undergoing lumbar spine surgery.

Quick facts

Study typeInterventional
Ages65 Years to 100 Years
SexAll
Enrollment120 (estimated)
SponsorPoznan University of Medical Sciences
Academic / other
Locations1 site (Poznan)
StatusRecruiting
StartedMay 25, 2026
Main results expectedJuly 31, 2027
Study endsAugust 31, 2027
Registry record updatedNovember 5, 2026
Trial IDNCT07607509 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Candidates are adults aged 65 or older undergoing elective lumbar spine surgery, able to consent and to assess pain, and without contraindications to regional anesthesia or ropivacaine.

Probably not a fit

Patients with contraindications to regional anesthesia, chronic opioid use, or those not benefiting from regional techniques may see no improvement in pain or opioid reduction.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized trial compares two regional anesthesia techniques—lumbar paravertebral block (L-PVB) and lumbar erector spinae plane block (L-ESPB)—in elderly patients undergoing elective lumbar spine surgery, in addition to standardized general anesthesia and multimodal analgesia. The primary outcome is total opioid consumption in the first 48 hours after surgery, measured in intravenous morphine equivalents. Secondary outcomes include postoperative pain scores, intraoperative opioid use, time to mobilization, hospital length of stay, and incidence of opioid-related adverse events. Eligible participants are adults aged 65 or older with ASA I–III, scheduled for elective lumbar procedures, and able to report pain on a numeric rating scale. The trial randomizes participants 1:1 to receive L-PVB, L-ESPB, or general anesthesia with standard analgesia alone, with ropivacaine used for blocks where applicable.

Why it matters

Potential benefit: If successful, the study could identify a regional technique that lowers opioid needs and improves recovery after lumbar surgery in older adults.

How similar studies have gone: Prior regional blocks show promise for analgesia in spine surgery, but direct elderly-focused comparisons between L-PVB and L-ESPB are limited, making this study relatively novel for this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ge ≥65 years
* Scheduled for elective lumbar spine surgery
* American Society of Anesthesiologists (ASA) physical status I-III
* Ability to assess pain using the Numeric Rating Scale (NRS)
* Provision of written informed consent

Exclusion Criteria:

* Refusal to participate
* Chronic opioid therapy
* Coagulation disorders
* Use of anticoagulant therapy contraindicating regional anesthesia
* Infection at the planned needle insertion site
* Allergy to ropivacaine or other study-related medications
* Severe hepatic failure
* Severe renal failure
* Cognitive impairment preventing reliable pain assessment
* Inability to cooperate with study procedures
* Extensive reoperation or surgery of unusually large extent that may interfere with outcome assessment
* Contraindications to general anesthesia or regional anesthesia

Where it's running

  • Poznan University of Medical Sciences
    Poznan, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.